Diabetic Emergencies: Recognition And Treatment

SECTION 1

Historical Context & Motivation

Before the discovery of insulin in the 1920s, diabetic ketoacidosis (DKA) was a uniformly fatal condition. Patients with type 1 diabetes who developed DKA progressed rapidly from polyuria and vomiting to coma and death within days. Similarly, hyperosmolar hyperglycemic state (HHS), though not formally described until the mid-twentieth century, carried a mortality rate exceeding 50 percent even in hospital settings. The evolution of our understanding of these two hyperglycemic crises mirrors the broader history of diabetes management, transitioning from near-certain death to a treatable, survivable emergency with modern protocols.

1886

Kussmaul Describes Diabetic Coma

Adolf Kussmaul characterizes the deep, labored breathing pattern seen in patients dying of diabetic coma, now known as Kussmaul respirations. This respiratory compensation for metabolic acidosis becomes a hallmark sign of DKA.

1922

Insulin Discovery and First Clinical Use

Banting and Best isolate insulin and administer it to Leonard Thompson, transforming DKA from a death sentence into a treatable condition. Mortality from DKA drops dramatically within a decade.

1957

HHS Formally Described

Sament and Schwartz publish the first formal clinical description of nonketotic hyperosmolar coma, distinguishing it from DKA. The condition is recognized as primarily affecting older adults with type 2 diabetes.

1973

Low-Dose Insulin Protocol Introduced

Alberti and colleagues demonstrate that continuous low-dose intravenous insulin infusion is as effective as high-dose boluses with fewer complications, establishing the modern treatment paradigm for both DKA and HHS.

2009

ADA Consensus Guidelines

The American Diabetes Association publishes comprehensive consensus guidelines for the management of hyperglycemic crises in adult patients, standardizing diagnostic criteria and treatment algorithms used in clinical practice today.

Despite nearly a century of insulin therapy and progressive refinement of treatment protocols, DKA and HHS remain life-threatening emergencies that nurses encounter regularly in acute care settings. DKA accounts for approximately 140,000 hospital admissions annually in the United States alone, while HHS, though less common, carries a mortality rate of 10 to 20 percent—roughly ten times that of DKA. The central clinical question for the NCLEX-RN and bedside practice alike is this: How does a nurse rapidly differentiate between DKA and HHS, and what are the priority interventions that prevent fatal outcomes?

SECTION 2

Core Principles & Pathophysiology

Both DKA and HHS arise from a fundamental imbalance between insulin availability and counterregulatory hormone activity. In DKA, an absolute or near-absolute insulin deficiency forces the body to rely on fatty acid oxidation for energy, generating ketone bodies (acetoacetate, β-hydroxybutyrate, and acetone) that accumulate and drive a severe metabolic acidosis. In HHS, a relative insulin deficiency is sufficient to prevent ketogenesis but not adequate to prevent extreme hyperglycemia and the resulting hyperosmolarity and profound dehydration. Understanding these divergent pathways is essential for prioritizing nursing interventions.

Insulin Deficiency Spectrum

DKA involves absolute insulin deficiency (often type 1 diabetes), whereas HHS involves relative deficiency (often type 2 diabetes). The degree of deficiency determines whether ketogenesis occurs.

Osmotic Diuresis and Dehydration

Uncontrolled hyperglycemia exceeds the renal threshold (≈180 mg/dL), causing glucose to spill into urine and drag water and electrolytes with it. HHS patients lose an average of 8–10 L of fluid; DKA patients typically lose 5–7 L.

Ketoacid Accumulation

In DKA, hepatic ketogenesis overwhelms the body's buffering capacity, leading to an increased anion gap metabolic acidosis with arterial pH often below 7.30 and serum bicarbonate below 18 mEq/L.

Electrolyte Derangements

Both conditions cause total body potassium depletion despite initial serum potassium appearing normal or elevated due to transcellular shift. As insulin is administered and acidosis corrects, potassium shifts intracellularly and hypokalemia can become life-threatening.

Precipitating Factors

The most common triggers are infection, insulin nonadherence, and new-onset diabetes. The mnemonic for DKA triggers is the '5 I's': Infection, Insulin deficiency, Infarction, Intoxication, and Infant (pregnancy).

✦ KEY TAKEAWAY

Think of insulin as the gatekeeper to a building. In DKA, the gatekeeper is completely absent—glucose cannot enter cells, and the body breaks down fat stores in desperation, producing toxic ketone byproducts that acidify the blood. In HHS, the gatekeeper is present but understaffed—enough insulin remains to prevent the fat-burning crisis, but glucose still accumulates to dangerously high levels in the bloodstream, pulling water out of cells through osmosis and causing devastating dehydration. Both scenarios demand immediate fluid resuscitation and insulin, but the presence or absence of ketoacidosis is the distinguishing clinical feature.

SECTION 3

Visual Explanation: DKA vs. HHS Pathophysiology

This diagram illustrates the divergent pathways of DKA (left, violet) and HHS (right, cyan). Both conditions originate from insulin deficiency, but the absolute deficiency in DKA triggers lipolysis and ketoacid production, while the relative deficiency in HHS preserves enough insulin action to prevent ketogenesis but cannot control hyperglycemia. Both pathways converge at severe dehydration (green), making aggressive fluid resuscitation the first priority in management.

As the diagram makes clear, the fundamental branch point is whether sufficient insulin remains to suppress hepatic ketogenesis. In DKA, the absence of insulin allows counterregulatory hormones (glucagon, cortisol, catecholamines, and growth hormone) to drive unopposed lipolysis. The liver converts free fatty acids into ketone bodies faster than peripheral tissues can utilize them, resulting in an accumulation of strong organic acids that deplete the body's bicarbonate buffering system. The patient compensates with deep, rapid Kussmaul respirations to blow off CO₂ and partially correct the pH. In contrast, the HHS patient retains enough insulin to prevent this ketogenic cascade but cannot prevent glucose levels from climbing above 600 mg/dL—sometimes exceeding 1,000 mg/dL—leading to serum osmolality values that cause profound neurological dysfunction, including altered mental status, seizures, and coma.

SECTION 4

Key Calculations & Clinical Parameters

Nurses must be able to interpret and calculate several laboratory values that guide the management of DKA and HHS. Understanding the formulas behind the anion gap, corrected sodium, and effective serum osmolality is essential for accurate assessment and monitoring of treatment response. These calculations help clinicians determine the severity of the crisis and guide decisions about fluid composition, insulin dosing, and electrolyte replacement.

ANION GAP

AG = Na⁺ − (Cl⁻ + HCO₃⁻)

Normal AG = 8–12 mEq/L. In DKA, the anion gap is typically > 12 mEq/L due to accumulation of unmeasured anions (ketoacids). An elevated AG confirms an anion-gap metabolic acidosis and helps differentiate DKA from hyperchloremic acidosis.

CORRECTED SODIUM

Na⁺(corrected) = Na⁺(measured) + 1.6 × [(Glucose − 100) ÷ 100]

Hyperglycemia causes osmotic water shift from the intracellular to extracellular space, diluting serum sodium. The corrected sodium accounts for this dilutional effect. A corrected sodium > 140 mEq/L suggests severe free water deficit, which is particularly concerning in HHS.

EFFECTIVE SERUM OSMOLALITY

Osm(eff) = 2 × Na⁺ + (Glucose ÷ 18)

Normal effective osmolality is 275–295 mOsm/kg. In HHS, values exceed 320 mOsm/kg. BUN is excluded because urea crosses cell membranes freely and does not contribute to the osmotic gradient that drives water out of cells. The degree of hyperosmolarity correlates with the severity of neurological symptoms.

⚠️ Clinical Pearl: Potassium Before Insulin

Before initiating insulin therapy, the nurse must verify the serum potassium level. If K⁺ is < 3.3 mEq/L, insulin administration is held and potassium is replaced first. Administering insulin to a hypokalemic patient can cause fatal cardiac arrhythmias as insulin drives potassium further into cells. This is a critical NCLEX-RN safety concept.

SECTION 5

DKA vs. HHS: Detailed Comparison

While DKA and HHS share a common origin in hyperglycemia and dehydration, their clinical presentations, laboratory profiles, and patient demographics differ substantially. The following comparison table is essential knowledge for the NCLEX-RN, as questions frequently require the nurse to differentiate between these two conditions based on laboratory values and clinical findings. Note that overlap syndromes can occur—approximately one-third of patients present with features of both DKA and HHS, particularly those with markedly elevated glucose levels alongside significant ketoacidosis.

Comparison of DKA and HHS diagnostic criteria and clinical features

Parameter	DKA	HHS
Typical Patient	Type 1 diabetes (can occur in type 2)	Type 2 diabetes, older adults
Onset	Rapid (hours to < 24 hours)	Gradual (days to weeks)
Blood Glucose	> 250 mg/dL (can be lower in euglycemic DKA)	> 600 mg/dL (often > 1,000)
Arterial pH	< 7.30 (severe: < 7.00)	> 7.30
Serum Bicarbonate	< 18 mEq/L (severe: < 10)	> 18 mEq/L
Anion Gap	Elevated (> 12 mEq/L)	Normal or mildly elevated
Serum Ketones	Positive (moderate to large)	Absent or trace
Effective Osmolality	Variable (often < 320 mOsm/kg)	> 320 mOsm/kg
Mental Status	Alert to stuporous	Stupor to coma (common)
Kussmaul Respirations	Present	Absent
Fluid Deficit	5–7 L average	8–10 L average
Mortality Rate	1–5%	10–20%

This clinical decision algorithm guides the nurse through the systematic assessment of a hyperglycemic patient. The branch point at serum ketone presence is the critical differentiating step. Once the condition is classified, priority interventions converge at IV fluids, potassium assessment, and insulin administration.

SECTION 6

Worked Example: Clinical Scenario

The following clinical scenario illustrates how a nurse uses laboratory values and clinical findings to differentiate between DKA and HHS and to prioritize interventions. This type of clinical reasoning is directly tested on the NCLEX-RN.

Case: 24-Year-Old with Type 1 Diabetes Presenting to the ED

Step 1 — Gather Clinical DataA 24-year-old female with a history of type 1 diabetes presents to the emergency department with nausea, vomiting, abdominal pain, and confusion. She reports running out of insulin three days ago. Vital signs: BP 92/58, HR 122, RR 28 (deep and rapid), T 37.8°C. She has a fruity odor on her breath. The nurse notes the Kussmaul respirations and fruity breath as classic signs of ketoacidosis.

Step 2 — Interpret Laboratory ResultsLaboratory results return: Blood glucose = 485 mg/dL, Na⁺ = 128 mEq/L, K⁺ = 5.8 mEq/L, Cl⁻ = 98 mEq/L, HCO₃⁻ = 8 mEq/L, BUN = 32 mg/dL, Creatinine = 1.6 mg/dL, Arterial pH = 7.12, Serum ketones = large positive. The nurse calculates the anion gap.

AG = 128 − (98 + 8) = 22 mEq/L (elevated)

Step 3 — Calculate Corrected SodiumBecause the glucose is significantly elevated, the measured sodium is diluted. The nurse calculates corrected sodium to assess the true hydration status: Na⁺(corrected) = 128 + 1.6 × [(485 − 100) ÷ 100] = 128 + 1.6 × 3.85 = 128 + 6.16.

Corrected Na⁺ = 134.2 mEq/L — this indicates significant free water deficit despite the low measured sodium.

Step 4 — Classify the ConditionThe nurse applies the diagnostic criteria: blood glucose > 250 ✓, arterial pH < 7.00 (severe) ✓, serum bicarbonate < 10 (severe) ✓, anion gap > 12 ✓, serum ketones positive ✓. The patient has Kussmaul respirations and fruity breath. Mental status is altered (confused/stuporous).

Diagnosis: Severe DKA

Step 5 — Prioritize Nursing InterventionsPriority 1: Establish two large-bore IV lines and begin aggressive fluid resuscitation with 0.9% normal saline at 1,000–1,500 mL/hour for the first hour. Priority 2: Assess potassium—K⁺ is 5.8 mEq/L (elevated due to acidosis and transcellular shift). Since K⁺ > 5.3, potassium replacement is not yet needed, but the nurse anticipates a rapid drop once insulin is started. Priority 3: Initiate continuous IV regular insulin infusion at 0.1–0.14 units/kg/hour. Priority 4: Monitor blood glucose every hour, BMP every 2–4 hours, and neurological status continuously. When blood glucose reaches 200 mg/dL, switch IV fluids to D5W with 0.45% NS to prevent hypoglycemia while continuing insulin until the anion gap normalizes.

Key nursing priority: Fluids first, potassium assessment second, insulin third — never give insulin if K⁺ < 3.3 mEq/L.

SECTION 7

Treatment Protocols: Strengths & Limitations

Modern treatment protocols for DKA and HHS follow a structured approach that addresses the three pillars of management: fluid resuscitation, insulin therapy, and electrolyte correction. While these protocols have dramatically improved outcomes compared to historical mortality rates, nurses must understand both the therapeutic rationale and the potential complications of each intervention. The table below outlines the key components of management along with their benefits and associated risks.

Management interventions with benefits and risks

Intervention	Therapeutic Benefit	Potential Complication
IV 0.9% NS (1–1.5 L/hr × 1 hr)	Restores intravascular volume, improves renal perfusion and glucose excretion, corrects hypotension	Fluid overload in elderly or cardiac patients; hyperchloremic metabolic acidosis with prolonged NS infusion
Continuous IV Insulin (0.1–0.14 U/kg/hr)	Suppresses ketogenesis, lowers blood glucose, corrects acidosis, shifts potassium intracellularly	Hypokalemia (potentially fatal), hypoglycemia if glucose not monitored hourly, cerebral edema (rare, pediatric)
Potassium Replacement (20–40 mEq/L in IV fluids)	Prevents life-threatening hypokalemia as insulin shifts K⁺ intracellularly and acidosis corrects	Hyperkalemia if administered too rapidly or with renal impairment; cardiac arrhythmias
Bicarbonate (only if pH < 6.9)	Addresses severe life-threatening acidosis that impairs cardiac contractility	Paradoxical CNS acidosis, hypokalemia, delayed ketone clearance; not routinely recommended
D5W + 0.45% NS (when BG ≤ 200–300)	Prevents hypoglycemia while allowing continued insulin infusion to close the anion gap	Delayed transition can cause rebound hyperglycemia; too-early transition may mask ongoing ketosis

✦ KEY TAKEAWAY

Think of treating DKA as defusing a bomb with three interconnected wires. The fluid wire must be cut first—without restoring volume, kidneys cannot excrete glucose and tissues cannot receive insulin. The potassium wire must be assessed before touching the insulin wire—cutting the insulin wire too early (before ensuring potassium is ≥ 3.3) causes the entire system to destabilize through fatal cardiac arrhythmia. The sequence matters as much as the intervention itself: fluids → potassium assessment → insulin. In HHS, the approach is similar but with more gradual glucose correction to prevent cerebral edema.

SECTION 8

Complications & Advanced Considerations

Successful resolution of DKA and HHS requires vigilant monitoring not only during the acute phase but also during the recovery period. Several iatrogenic complications can arise from treatment itself, and the nurse must anticipate and prevent these through careful assessment and monitoring protocols. Additionally, understanding the resolution criteria for each condition is essential for transitioning the patient from intravenous to subcutaneous insulin—a critical window where many patients experience rebound hyperglycemia or recurrent DKA if overlap dosing is not maintained.

Treatment complications with nursing prevention strategies

Complication	Mechanism	Nursing Prevention / Monitoring
Hypokalemia	Insulin drives K⁺ into cells; correction of acidosis reduces H⁺/K⁺ exchange; renal excretion of K⁺ resumes with fluid resuscitation	Monitor K⁺ every 2 hours; replace in IV fluids when K⁺ < 5.3; hold insulin if K⁺ < 3.3; continuous cardiac monitoring
Cerebral Edema	Too-rapid correction of osmolality causes water to shift into brain cells; more common in pediatric DKA and severe HHS	Lower glucose no faster than 50–75 mg/dL per hour; neurological checks every hour; watch for headache, altered LOC, bradycardia
Hypoglycemia	Continued insulin infusion after glucose normalizes without dextrose supplementation	Hourly BG monitoring; add D5W to IV when BG reaches 200 (DKA) or 300 (HHS); never discontinue insulin until resolution criteria met
Rebound Hyperglycemia / Recurrent DKA	Insulin drip discontinued before subcutaneous insulin has reached therapeutic levels (IV insulin half-life is only 5–10 minutes)	Overlap subcutaneous basal insulin with IV infusion by 1–2 hours before discontinuing the drip; ensure patient is eating before stopping IV insulin
Venous Thromboembolism	Severe dehydration, immobility, and hyperosmolarity increase clotting risk, particularly in HHS	DVT prophylaxis (LMWH or SCDs); encourage early mobility; monitor for signs of PE or DVT

📋 DKA Resolution Criteria (ADA Guidelines)

DKA is considered resolved when all three criteria are met: (1) Blood glucose < 200 mg/dL, (2) serum bicarbonate ≥ 15 mEq/L, and (3) venous pH > 7.30. Additionally, the anion gap should be ≤ 12 mEq/L. Do not transition to subcutaneous insulin until these criteria are met AND the patient is able to tolerate oral intake.

Looking forward, emerging technologies such as continuous glucose monitors (CGMs) and closed-loop insulin delivery systems are transforming the prevention of diabetic emergencies. Patients who use these devices experience significantly fewer DKA episodes, and hospital-based CGMs are beginning to supplement the hourly point-of-care glucose checks that currently define acute management. Additionally, research into SGLT2 inhibitors has identified a new phenotype—euglycemic DKA—in which patients present with classic DKA acidosis but blood glucose levels below 250 mg/dL, requiring clinicians to maintain a high index of suspicion even when glucose levels appear relatively normal.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A nursing student asks why DKA produces an anion gap metabolic acidosis while HHS does not. Explain the pathophysiological difference that accounts for the presence of ketoacidosis in DKA but not in HHS.

PROBLEM 2 — BASIC CALCULATION

A patient presents with the following labs: Na⁺ = 132 mEq/L, Cl⁻ = 100 mEq/L, HCO₃⁻ = 10 mEq/L, blood glucose = 420 mg/dL. Calculate the anion gap and the corrected sodium. Based on these values, is this patient more likely in DKA or HHS?

PROBLEM 3 — INTERMEDIATE

A nurse is caring for a patient being treated for severe DKA with a continuous insulin infusion at 0.14 units/kg/hr. The patient weighs 70 kg. Two hours into treatment, the blood glucose drops from 520 mg/dL to 340 mg/dL (a drop of 180 mg/dL in 2 hours). The serum potassium has decreased from 5.4 to 4.0 mEq/L. What nursing actions are appropriate at this time? Should the nurse be concerned about the rate of glucose decline?

PROBLEM 4 — APPLIED

An 82-year-old nursing home resident with type 2 diabetes and dementia is brought to the emergency department after being found unresponsive. Labs reveal: BG = 1,050 mg/dL, Na⁺ = 149 mEq/L, K⁺ = 4.8 mEq/L, HCO₃⁻ = 22 mEq/L, pH = 7.34, serum ketones = trace, BUN = 58 mg/dL, creatinine = 2.4 mg/dL. Calculate the effective serum osmolality. Identify the condition and outline the nursing priorities specific to this presentation.

PROBLEM 5 — CRITICAL THINKING

A 45-year-old patient with type 2 diabetes who recently started an SGLT2 inhibitor (empagliflozin) presents with nausea, vomiting, abdominal pain, and Kussmaul respirations. Blood glucose is 195 mg/dL, pH is 7.18, HCO₃⁻ is 9 mEq/L, anion gap is 24, and serum ketones are large positive. The emergency physician initially dismisses DKA because the glucose is below 250 mg/dL. As the nurse, how should you advocate for this patient? Explain the concept of euglycemic DKA and why SGLT2 inhibitors predispose patients to this condition.

SUMMARY

Summary & Key Concepts

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are life-threatening hyperglycemic emergencies that differ fundamentally in their pathophysiology. DKA results from absolute insulin deficiency leading to ketoacid accumulation and anion gap metabolic acidosis, typically in type 1 diabetes patients with rapid onset. HHS results from relative insulin deficiency causing extreme hyperglycemia (> 600 mg/dL) and hyperosmolarity (> 320 mOsm/kg) without significant ketosis, typically in older adults with type 2 diabetes over days to weeks. Key differentiating features include the presence of Kussmaul respirations, fruity breath, and positive serum ketones in DKA versus profound alteration in mental status and extreme dehydration in HHS.

The management of both conditions follows the same critical sequence: aggressive IV fluid resuscitation with 0.9% NS first, potassium assessment and replacement second (hold insulin if K⁺ < 3.3 mEq/L), and continuous IV insulin infusion third. Essential calculations include the anion gap (Na⁺ − [Cl⁻ + HCO₃⁻]), corrected sodium, and effective serum osmolality. Critical complications to monitor include hypokalemia, cerebral edema, and hypoglycemia. DKA resolution requires pH > 7.30, HCO₃⁻ ≥ 15, and BG < 200 before transitioning to subcutaneous insulin, with a mandatory 1–2 hour overlap. Finally, nurses must be aware of euglycemic DKA associated with SGLT2 inhibitors, where classic DKA develops with near-normal glucose levels—reinforcing the principle that clinical assessment, not a single lab value, drives diagnosis and intervention.